Cargando…

Predictive role of galectin-1 and integrin α5β1 in cisplatin-based neoadjuvant chemotherapy of bulky squamous cervical cancer

Although galectin-1 and integrin α5β1 confer chemoresistance to certain types of cancer, whether their expression predicts the response to cisplatin-based neoadjuvant chemotherapy (NACT) in squamous cervical cancer remains unclear. Paired tumor samples (pre- and post-chemotherapy) were obtained from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Haiyan, Chen, Aixue, Li, Saisai, Tao, Xuejiao, Sheng, Bo, Chetry, Mandika, Zhu, Xueqiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617914/ https://www.ncbi.nlm.nih.gov/pubmed/28842515 http://dx.doi.org/10.1042/BSR20170958

Ejemplares similares

Effects of Galectin-1 on Biological Behavior in Cervical Cancer
por: Chetry, Mandika, et al.
Publicado: (2020)

Effects of Galectin-1 on Biological Behavior in Cervical Cancer: Erratum
por: Chetry, Mandika, et al.
Publicado: (2022)

The Role of Galectins in Tumor Progression, Treatment and Prognosis of Gynecological Cancers
por: Chetry, Mandika, et al.
Publicado: (2018)

Overexpression of Galectin10 Predicts a Better Prognosis in Human Ovarian Cancer
por: Jiang, Wenxiao, et al.
Publicado: (2021)

Prognostic values of aquaporins mRNA expression in human ovarian cancer
por: Chetry, Mandika, et al.
Publicado: (2018)

Expression of thioredoxin 1 and peroxiredoxins in squamous cervical carcinoma and its predictive role in NACT
por: Zhu, Haiyan, et al.
Publicado: (2019)

Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy
por: Choi, Chel Hun, et al.
Publicado: (2008)

Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer
por: Li, Jing, et al.
Publicado: (2016)

Prognostic values of DNA mismatch repair genes in ovarian cancer patients treated with platinum-based chemotherapy
por: Zhao, Chuchu, et al.
Publicado: (2017)

Prognostic role of overexpressed Bromodomain and extra-terminal family in ovarian cancer
por: Chetry, Mandika, et al.
Publicado: (2022)

Neoadjuvant chemotherapy using platinum- and taxane-based regimens for bulky stage Ib2 to IIb non-squamous cell carcinoma of the uterine cervix
por: Shoji, Tadahiro, et al.
Publicado: (2012)

Molecular mechanisms of cisplatin resistance in cervical cancer
por: Zhu, Haiyan, et al.
Publicado: (2016)

Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment
por: Byrski, T, et al.
Publicado: (2012)

S100A9 regulates cisplatin chemosensitivity of squamous cervical cancer cells and related mechanism
por: Zhao, Chuchu, et al.
Publicado: (2018)

A retrospective study of neoadjuvant chemotherapy plus radical hysterectomy versus radical hysterectomy alone in patients with stage II cervical squamous cell carcinoma presenting as a bulky mass
por: Takatori, Eriko, et al.
Publicado: (2016)

Neoadjuvant PD‐1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung
por: Feng, Yuan, et al.
Publicado: (2021)

Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass
por: Shoji, Tadahiro, et al.
Publicado: (2016)

Radical Hysterectomy After Neoadjuvant Chemotherapy for Locally Bulky-Size Cervical Cancer: A Retrospective Comparative Analysis between the Robotic and Abdominal Approaches
por: Liu, Chia-Hao, et al.
Publicado: (2019)

Laparoscopic Radical Trachelectomy after Neoadjuvant Chemotherapy for Fertility Preservation in Early-Stage Bulky Cervical Cancer: A Case Report and Literature Review
por: Vasilevska, Danuta, et al.
Publicado: (2022)

Primary results of a randomized two‐by‐two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S‐1 and docetaxel/cisplatin/S‐1 as neoadjuvant chemotherapy for advanced gastric cancer
por: Hayashi, Tsutomu, et al.
Publicado: (2020)

Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer
por: Sugiyama, T, et al.
Publicado: (1999)

Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis
por: Xu, Jian, et al.
Publicado: (2019)

Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2)
por: Akhavan, Setareh, et al.
Publicado: (2021)

PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer
por: Zhu, Haiyan, et al.
Publicado: (2016)

Galectin-3 alters the lateral mobility and clustering of β1-integrin receptors
por: Yang, Esther H., et al.
Publicado: (2017)

Galectin-1-Induced Autophagy Facilitates Cisplatin Resistance of Hepatocellular Carcinoma
por: Su, Yu-Chi, et al.
Publicado: (2016)

Efficacy of neoadjuvant platinum-based chemotherapy during the second and third trimester of pregnancy in women with cervical cancer: an updated systematic review and meta-analysis
por: Song, Yizuo, et al.
Publicado: (2018)

Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
por: Li, Jing, et al.
Publicado: (2023)

Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical Cancer
por: Punt, Simone, et al.
Publicado: (2015)

Galectin-3 Binding to α(5)β(1) Integrin in Pore Suspended Biomembranes
por: Sarangi, Nirod Kumar, et al.
Publicado: (2022)

Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
por: Zhang, P, et al.
Publicado: (2014)

An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer
por: Xylinas, Evanguelos, et al.
Publicado: (2016)

Prognostic value of progesterone receptor expression in ovarian cancer: a meta-analysis
por: Luo, Hui, et al.
Publicado: (2017)

The prognostic values of signal transducers activators of transcription family in ovarian cancer
por: Li, Saisai, et al.
Publicado: (2017)

Can a bulky glycocalyx promote catch bonding in early integrin adhesion? Perhaps a bit
por: Blanchard, Aaron
Publicado: (2023)

Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma
por: Scandurra, Giuseppa, et al.
Publicado: (2015)

Neoadjuvant chemotherapy for penile cancer enabling organ preservation: A case of individualized management for bilateral lymph node metastasis and a bulky primary tumor
por: Asghar, Aeen M., et al.
Publicado: (2018)

Survival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer
por: Lim, Myong Cheol, et al.
Publicado: (2017)

Neoadjuvant chemoradiotherapy for locally advanced gastric cancer with bulky lymph node metastasis: Five case reports
por: Nomura, Eiji, et al.
Publicado: (2020)

Integrin-linked kinase affects the sensitivity of esophageal squamous cell carcinoma cells to chemotherapy with cisplatin via the Wnt/beta-catenin signaling pathway
por: Xu, Ting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r6oapd7llfepj7pqts9ug82mhd